A tragic error at a Texas pharmacy has led to the death of a 92-year-old man, sparking a wrongful death lawsuit that alleges a catastrophic mix-up of prescriptions. This devastating incident highlights the critical importance of accuracy in medication dispensing and raises serious questions about patient safety protocols.
Joseph Hamilton Broussard, a longtime customer of Mercury Drive Pharmacy, reportedly took medication for 66 days that was not intended for him, a mistake that his daughter's lawsuit claims ultimately proved fatal. The legal complaint, filed in Harris County District Court, details an 11-month decline in Mr. Broussard's health following the dispensing of the incorrect drug.
An expert medical opinion, submitted by a physician specializing in emergency medicine and toxicology, strongly supports the claim that the wrong medication was the direct cause of Mr. Broussard's death. This expert specifically called out Mercury Drive Pharmacy for "negligence and breaches in the standard of care." The opinion emphasizes a fundamental tenet of pharmacy practice: "one of the most fundamental checks is to ensure before a medication is given or delivered to a patient that the name on the pill bottle matches the name of the patient it is being given to."
But here's where it gets particularly concerning: Mercury Drive Pharmacy is part of the Health Mart network, which is owned by McKesson, a major pharmaceutical distributor. Despite multiple attempts to reach McKesson for comment, no response was provided. Similarly, an employee at Mercury Drive stated they could not relay a message to the owner, and an email to the owner went unanswered.
Mr. Broussard, who had a complex medical history including a pacemaker, type 2 diabetes, high blood pressure, high cholesterol, atrial fibrillation, congestive heart failure, and a past battle with cancer that resulted in partial kidney removal, was receiving his prescription refills by mail. On August 8, 2024, a bottle containing 90 tablets of pioglitazone, a diabetes medication also known as Actos, arrived at his Houston home. He diligently followed the prescribed dosage of one pill per day.
However, the lawsuit alleges that Mr. Broussard had never been prescribed pioglitazone. The medication was intended for another patient entirely. This is the part most people miss – a simple error in labeling or dispensing could have such profound consequences.
Months later, in October, Mr. Broussard was hospitalized with shortness of breath and swollen ankles. Doctors identified water retention due to a worsening of his congestive heart failure, requiring a two-day hospital stay. Later, following a bout of pneumonia, he was hospitalized again for an entire week with "congestive heart failure exacerbation."
The expert opinion, filed alongside the lawsuit, reveals that 24 of the 90 pioglitazone pills remained when the case was reviewed. Dr. Jonathan David de Olano, the medical expert, stated, "Had Mr. Broussard not received this medication, it is more likely than not he would not have had an exacerbation of congestive heart failure or required hospitalization that he did."
Dr. de Olano further explained that pioglitazone is known to promote fluid retention and can "trigger or worsen heart failure, particularly in individuals with pre-existing congestive heart failure, such as Mr. Broussard." He stressed the need for careful monitoring, as "volume overload may develop gradually and produce significant clinical consequences." Based on a reasonable degree of medical probability, Dr. de Olano believes it is highly likely that Mr. Broussard's ingestion of pioglitazone directly contributed to his hospitalizations and eventual death.
The lawsuit claims that Mercury Drive Pharmacy acted with "conscious indifference to Broussard’s rights, safety, health and welfare." Mr. Broussard's daughter is seeking substantial damages to cover his physical and emotional suffering, medical expenses, funeral costs, and punitive damages to punish and deter such gross negligence in the future.
This case echoes other tragic incidents. In 2019, a pharmacy technician's error led to a patient's death after receiving the wrong cancer drug. Last year, a pharmacist accidentally prescribed a lethal dose of painkillers. In some extreme cases, healthcare professionals have even faced manslaughter charges for medication errors.
What do you think about the level of oversight in pharmacies? Should there be stricter regulations, or are these isolated incidents? Share your thoughts in the comments below – we’d love to hear your perspective!
